Bimzelx Mechanism of Action. New mAb to Clear IL-17
Bimzelx (Bimekizumab) is a monoclonal antibody, which calms down inflammation in psoriasis and psoriatic arthritis by binding and blocking two pro-inflammatory molecules: Filling two needs with one dead, scientists developed an antibody against a site common for both A and F subtypes of interleukin 17. It allowed bimekizumab to completely shoutdown this signalling molecule from … Read more